Methylsulfonylmethane ameliorates metabolic-associated fatty liver disease by restoring autophagy flux via AMPK/mTOR/ULK1 signaling pathway

• Main Authors: Daewon Han (Author), Deokryong Kim (Author), Haeil Kim (Author), Jeonga Lee (Author), Jungmook Lyu (Author), Jong-Seok Kim (Author), Jongdae Shin (Author), Jeong Sig Kim (Author), Do Kyung Kim (Author), Hwan-Woo Park (Author)
• Format: Book
• Published: Frontiers Media S.A., 2023-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Introduction: Metabolism-associated fatty liver disease (MAFLD) is a global health concern because of its association with obesity, insulin resistance, and other metabolic abnormalities. Methylsulfonylmethane (MSM), an organic sulfur compound found in various plants and animals, exerts antioxidant a...